GJB2 and hearing loss disorder: Clarifying the molecular pathophysiology and phenotypic spectrum of GJB2-related hearing loss is essential to define the natural history of GJB2 deafness and lay the clinical foundation for future gene, cell, and drug-based therapeutics.